123 related articles for article (PubMed ID: 11349830)
1. Mitochondrial activity in XTC.UC1 cells derived from thyroid oncocytoma.
Savagner F; Chevrollier A; Loiseau D; Morgan C; Reynier P; Clark O; Stepien G; Malthiery Y
Thyroid; 2001 Apr; 11(4):327-33. PubMed ID: 11349830
[TBL] [Abstract][Full Text] [Related]
2. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
Bonora E; Porcelli AM; Gasparre G; Biondi A; Ghelli A; Carelli V; Baracca A; Tallini G; Martinuzzi A; Lenaz G; Rugolo M; Romeo G
Cancer Res; 2006 Jun; 66(12):6087-96. PubMed ID: 16778181
[TBL] [Abstract][Full Text] [Related]
3. Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors.
Savagner F; Franc B; Guyetant S; Rodien P; Reynier P; Malthiery Y
J Clin Endocrinol Metab; 2001 Oct; 86(10):4920-5. PubMed ID: 11600563
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial activities of a cell line derived from thyroid Hürthle cell tumors.
Stankov K; Biondi A; D'Aurelio M; Gasparre G; Falasca A; Romeo G; Lenaz G
Thyroid; 2006 Apr; 16(4):325-31. PubMed ID: 16646677
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration.
Ferreira-da-Silva A; Valacca C; Rios E; Pópulo H; Soares P; Sobrinho-Simões M; Scorrano L; Máximo V; Campello S
PLoS One; 2015; 10(3):e0122308. PubMed ID: 25822260
[TBL] [Abstract][Full Text] [Related]
6. Characterization of metabolic reprogramming by metabolomics in the oncocytic thyroid cancer cell line XTC.UC1.
Kurashige T; Shimamura M; Hamada K; Matsuse M; Mitsutake N; Nagayama Y
Sci Rep; 2023 Jan; 13(1):149. PubMed ID: 36599897
[TBL] [Abstract][Full Text] [Related]
7. Selenoprotein expression in Hürthle cell carcinomas and in the human Hürthle cell carcinoma line XTC.UC1.
Menth M; Schmutzler C; Mentrup B; Hoang-Vu C; Takahashi K; Honjoh T; Köhrle J
Thyroid; 2005 May; 15(5):405-16. PubMed ID: 15929660
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of Parkin-mediated mitophagy in thyroid Hürthle cell tumors.
Lee J; Ham S; Lee MH; Kim SJ; Park JH; Lee SE; Chang JY; Joung KH; Kim TY; Kim JM; Sul HJ; Kweon GR; Jo YS; Kim KS; Shong YK; Gasparre G; Chung JK; Porcelli AM; Shong M
Carcinogenesis; 2015 Nov; 36(11):1407-18. PubMed ID: 26354775
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming related to whole-chromosome instability in models for Hürthle cell carcinoma.
Addie RD; Kostidis S; Corver WE; Oosting J; Aminzadeh-Gohari S; Feichtinger RG; Kofler B; Aydemirli MD; Giera M; Morreau H
Sci Rep; 2020 Jun; 10(1):9578. PubMed ID: 32533088
[TBL] [Abstract][Full Text] [Related]
10. PGC-1-related coactivator and targets are upregulated in thyroid oncocytoma.
Savagner F; Mirebeau D; Jacques C; Guyetant S; Morgan C; Franc B; Reynier P; Malthièry Y
Biochem Biophys Res Commun; 2003 Oct; 310(3):779-84. PubMed ID: 14550271
[TBL] [Abstract][Full Text] [Related]
11. Coordinate expression of nuclear and mitochondrial genes involved in energy production in carcinoma and oncocytoma.
Heddi A; Faure-Vigny H; Wallace DC; Stepien G
Biochim Biophys Acta; 1996 Aug; 1316(3):203-9. PubMed ID: 8781539
[TBL] [Abstract][Full Text] [Related]
12. Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors.
Tallini G; Ladanyi M; Rosai J; Jhanwar SC
Cytogenet Cell Genet; 1994; 66(4):253-9. PubMed ID: 7909283
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors.
Baris O; Savagner F; Nasser V; Loriod B; Granjeaud S; Guyetant S; Franc B; Rodien P; Rohmer V; Bertucci F; Birnbaum D; Malthièry Y; Reynier P; Houlgatte R
J Clin Endocrinol Metab; 2004 Feb; 89(2):994-1005. PubMed ID: 14764826
[TBL] [Abstract][Full Text] [Related]
14. Respiratory complex I dysfunction due to mitochondrial DNA mutations shifts the voltage threshold for opening of the permeability transition pore toward resting levels.
Porcelli AM; Angelin A; Ghelli A; Mariani E; Martinuzzi A; Carelli V; Petronilli V; Bernardi P; Rugolo M
J Biol Chem; 2009 Jan; 284(4):2045-52. PubMed ID: 19047048
[TBL] [Abstract][Full Text] [Related]
15. Plasma membrane oxidoreductase activity in cultured cells in relation to mitochondrial function and oxidative stress.
Deleonardi G; Biondi A; D'Aurelio M; Pich MM; Stankov K; Falasca A; Formiggini G; Bovina C; Romeo G; Lenaz G
Biofactors; 2004; 20(4):251-8. PubMed ID: 15706061
[TBL] [Abstract][Full Text] [Related]
16. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC
Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852
[TBL] [Abstract][Full Text] [Related]
17. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
19. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.
Mayr JA; Meierhofer D; Zimmermann F; Feichtinger R; Kögler C; Ratschek M; Schmeller N; Sperl W; Kofler B
Clin Cancer Res; 2008 Apr; 14(8):2270-5. PubMed ID: 18413815
[TBL] [Abstract][Full Text] [Related]
20. Molecular features of thyroid oncocytic tumors.
Gasparre G; Bonora E; Tallini G; Romeo G
Mol Cell Endocrinol; 2010 May; 321(1):67-76. PubMed ID: 20184940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
